Implementation Intention Planning Guide for FIT Colon Cancer Screening
Impact of an Implementation Intention Planning Guide on Fecal Immunochemical Tests (FIT) Completion Rates
1 other identifier
interventional
1,600
1 country
5
Brief Summary
Fecal immunochemical tests (FIT) are a primary method of screening for colorectal cancer (CRC). Implementation intention planning involves encouraging completion or eliminating barriers for the participant to make a plan to complete a behavior or activity. This randomized control study seeks to answer whether the addition of an implementation intention guide impacts behaviors when completing FIT screening. The primary objective includes determining if the implementation intention guide increases completion rate of screening FIT. The secondary objectives is whether this intervention decreases the lab sample rejection rate and reduces the duration between sample collection and laboratory receipt/evaluation of screening FIT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 29, 2025
CompletedFirst Posted
Study publicly available on registry
September 19, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2026
ExpectedSeptember 19, 2025
July 1, 2025
6 months
July 29, 2025
September 18, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
FIT completion rate
Percentage of participants who have completed, returned, and have received completed lab results for FIT 90 days following participant reception of FIT.
Through study completion, approximately 12-18 months
Secondary Outcomes (2)
Duration between FIT collection date and receipt by the laboratory
Through study completion, approximately 12-18 months
Rate of lab sample rejection
Through study completion, approximately 12-18 months
Study Arms (2)
Control Arm (FIT Standard of Care)
NO INTERVENTIONThe Control Arm will receive the fecal immunochemical test (FIT) standard of care. Participants in this arm will be evaluated by their ordering provider about their eligibility and appropriateness for FIT for colorectal cancer screening. If appropriate, these participants will receive the FIT, instructions, and any other documentations always provided to participants receiving FIT in clinical practice. Any follow-up materials or communications with their provider will also follow FIT standard of care. They will not receive any additional document/implementation intention guide with their FIT.
Intervention Arm (FIT Standard of Care with Implementation Intention Guide)
EXPERIMENTALThe Intervention Arm will receive the fecal immunochemical test (FIT) standard of care and the implementation intention guide one-page document. Participants in this arm will be evaluated by their ordering provider about their eligibility and appropriateness for FIT for colorectal cancer screening. If appropriate, these participants will receive the FIT, instructions, and any other documentations always provided to participants receiving FIT in clinical practice. They will also receive the implementation intention guide being evaluated in this study. Any follow-up materials or communications with their provider will also follow FIT standard of care.
Interventions
The intervention is the addition of implementation intention guide document provided with the FIT. This is a one-page piece of paper that was developed by the investigator team and finalized with input/feedback from patient partners. The implementation intention guide includes instructions about the importance of developing a plan to complete FIT. It also includes fillable fields for participants to enter their plan for when to complete, where to store, when to return, and where to return their FIT. Participants will also be able to follow a QR code on the implementation intention guide document to a link to complete an anonymous, electronic version of the guide and share feedback on the intervention.
Eligibility Criteria
You may qualify if:
- Age 45-75
- Cared for by primary care at General Internal Medicine Clinic, Dartmouth-Hitchcock Medical Center (Lebanon, NH), Dartmouth Hitchcock Clinics Heater Road Primary Care (Lebanon, NH), Dartmouth Hitchcock Clinics Lyme Primary Care (Lyme, NH), or White River Junction Veterans Affairs Medical Center (White River Junction, VT) OR eligible for FIT through VA Mailed FIT Program
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Dartmouth Hitchcock Clinics, Heater Road Primary Care
Lebanon, New Hampshire, 03766, United States
Dartmouth-Hitchcock Medical Center, General Internal Medicine Clinic
Lebanon, New Hampshire, 03766, United States
Dartmouth Hitchcock Clinics, Lyme Primary Care Clinic
Lyme, New Hampshire, 03768, United States
White River Junction Veterans Affairs Medical Center, Primary Care Clinic
White River Junction, Vermont, 05009, United States
White River Junction Veterans Affairs Medical Center, VA Mailed FIT Program
White River Junction, Vermont, 05009, United States
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director, Comprehensive Gastroenterology Center; Professor of Medicine, Geisel School of Medicine and the Dartmouth Institute; Staff physician, Gastroenterology and Hepatology
Study Record Dates
First Submitted
July 29, 2025
First Posted
September 19, 2025
Study Start
October 1, 2025
Primary Completion
March 31, 2026
Study Completion (Estimated)
June 30, 2026
Last Updated
September 19, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share